Clinical trial
Paraoxonase and LDL Oxidation in Carotid Artery Disease
NCT00011258 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00011258 |
|---|---|
| Title | Paraoxonase and LDL Oxidation in Carotid Artery Disease |
| Official title | Paraoxonase and LDL Oxidation in Carotid Artery Disease |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Carotid Stenosis |
| Intervention type | Drug |
| Interventions | Paraoxonase |
| Enrollment | 1,000 |
| Start date | Mar 1, 1997 |
| Completion | Sep 1, 2003 |
| First posted | Feb 16, 2001 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: